Reckitt and Colman Report issue

For profit Phase 4
Founded: Slough United Kingdom (1938)
Status: Acquired by Reckitt Benckiser Pharmaceutical (1999)

Organization Overview

First Clinical Trial
1999
NCT00007527
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1999

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Reckitt & Colman

Active Ingredients

Drugs in Phase 4 Trials (2)

buprenorphine (1 trial)

naloxone (narcan) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Opioid-Related Disorders (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2